Becton, Dickinson and Company controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2025
BD Alaris pump Class I voluntary recall expansion
BD expanded a voluntary Class I recall concerning certain BD Alaris Pump Module model 8100 configurations used with a subset of compatible infusion sets. The FDA-described issue involved possible pump-performance variation under certain use cases compared with the performance described in the user manual, with potential implications for infusion delivery. The matter is treated as a product-safety and regulatory event rather than a finding of intentional misconduct.